[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 469
Citations 0
Correction
December 2013

Incorrect Number in Text

JAMA Surg. 2013;148(12):1086. doi:10.1001/jamasurg.2013.5153

In the Review titled “Breast Cancer: A Review for the General Surgeon” published online August 28, 2013, and in the October print issue of JAMA Surgery (2013;148[10]:971-979. doi:10.1001/jamasurg.2013.3393), an incorrect number appeared in the text. On page 975, the last sentence of the first paragraph should have read as follows: “To reiterate, in patients with tumors less than 5 cm, clinically lymph node–negative axilla, less than 3 positive lymph nodes, and treatment with breast-conserving therapy (to include whole-breast radiation) and adjuvant systemic hormonal therapy or chemotherapy, completion axillary lymph node dissection can be safely omitted.” This article was corrected online.

×